NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I agree that it delays the treatment coming to market, but it also demonstrates its efficacy potentially if it is given at different stages, which will help patients who don't get DCVax only at the beginning of their treatment.

Additionally, I disagree and think it's patently false that it "will actually cost more lives than it saves ..." It's a limited number during that time, and once it is approved, a much larger class of patients will be demonstrated to benefit, and that number is without definition, forever into the future, unless better treatments come along. So the future group is unlimited and larger, while the delay is a very definitely smaller number, and a more narrow number of patients.

So that point doesn't really make sense. But I do understand the impatience of real patients who need the treatment.